Medical image-sharing software provider Life Image has formed a strategic partnership with Mendel.ai, the developer of an artificial intelligence (AI) platform for oncology clinical trials.
Designed to facilitate the adoption of AI in site selection and patient recruitment for oncology trials, Mendel.ai's Mendel Brain software analyzes clinical data at a site location to identify patient cohorts for a given study protocol, according to the companies. The firms said the software can also proactively identify potential trials for patients by comparing their electronic medical record data with a trial database curated from more than 40,000 sources.
Life Image said it will offer Mendel Brain as a component of its Interoperability Suite for its network of research hospitals.
